Streetbeat News

Stock Prices

CLVR

Clever Leaves Holdings Inc. (NASDAQ:CLVR) announced its plan to voluntarily delist from NASDAQ due to financial strains, aiming to reduce operational costs and regulatory compliance burdens. The delisting process is set to begin around May 6, with the final trading day on NASDAQ expected around May 16. This move is part of a broader restructuring plan, following a 60% plunge in share value since the announcement. Despite a revenue increase and operational efficiencies reported in 2023, the company faces challenges in the cannabis industry.

Portfolio Pulse from Rolando García

April 30, 2024 | 4:09 pm

AAPL

GOOG

VGT

XLK

Apple Inc has established a secretive AI lab in Zurich, recruiting AI experts from Google, aiming to enhance iPhone capabilities. The lab focuses on advanced AI models crucial for new product development. Apple plans to introduce new AI features at its Worldwide Developers Conference, potentially boosting its stock. Analysts expect a slight revenue increase for the March quarter but a guide-down for June, with a focus on revenue from China and growth in Services revenue. Apple's stock has seen over 2% growth in the last 12 months, with exposure available through VGT and XLK ETFs.

Portfolio Pulse from Anusuya Lahiri

April 30, 2024 | 4:07 pm

PARA

Paramount Global reported Q1 results with revenue missing estimates and EPS beating estimates. The company announced CEO Bob Bakish's departure, replaced by a 3-person team. Analysts are divided on Paramount's value, citing uncertainty around potential merger activity and leadership changes. Bank of America sees shares as volatile, KeyBanc highlights a potential merger with Skydance impacting Class B shareholders, Needham downgrades due to leadership and strategic uncertainty, and Benchmark suggests a deal may be imminent but remains optimistic.

Portfolio Pulse from Chris Katje

April 30, 2024 | 4:07 pm

CNPOF

RIV Capital Inc. (OTC:CNPOF) reported a revenue increase to $2.1 million in CQ4 2023 from $1.9 million in CQ4 2022, driven by retail and wholesale sales of Etain-branded products in New York. Despite revenue growth, the company faced a gross loss of $0.6 million due to increased costs and an impairment charge of $48.7 million related to its acquisition of Etain, leading to a net loss of $47.3 million for CQ4 2023.

Portfolio Pulse from Rolando García

April 30, 2024 | 4:06 pm

NAUT

Nautilus Biotechnology's stock price increased following the announcement of their Q1 earnings per share (EPS) results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 4:03 pm

IBM

Investors have shown a bullish stance on IBM (NYSE:IBM), with options trading indicating a target price range of $110 to $200. Recent options activity includes 12 significant trades, with a sentiment split of 58% bullish and 41% bearish. The trading volume and open interest in IBM's options have been analyzed, highlighting substantial trades within the $110 to $200 strike price range. IBM's current market status shows a slight price decrease, with an earnings announcement expected in 78 days. Professional analysts have provided mixed ratings, with an average price target of $173.8.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 4:01 pm

CVS

Deep-pocketed investors have shown a bullish trend in CVS Health (NYSE:CVS) options trading, with a significant portion of activity leaning towards bullish sentiments. Benzinga's options scanner revealed 12 extraordinary activities, with a price target range from $50.0 to $72.0. The trading includes both puts and calls, with the largest trades indicating a mix of bullish and bearish sentiments. CVS Health, a major healthcare services provider, has seen its stock price slightly down with analysts giving mixed reviews but generally positive price targets.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 4:01 pm

RVTY

Analysts have updated their ratings and price targets for Revvity (NYSE:RVTY), showing a positive shift in sentiment with an average 12-month price target of $123.25, up 13.59% from the previous $108.50. The company, operating in diagnostics and discovery/analytical solutions, faces a revenue decline of -6.11% over the last 3 months but maintains a strong net margin of 11.29%. Despite challenges in revenue growth and ROE, Revvity's prudent debt management and profitability are highlighted.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 4:01 pm

NKE

Analyst ratings for Nike (NYSE:NKE) over the last quarter show a mix of bullish to bearish sentiments among 29 analysts, with a shift towards more conservative ratings in the last 30 days. The average 12-month price target for Nike is now $114.28, down 7.84% from the previous target, reflecting a cautious outlook from analysts. Recent actions include both downgrades and maintenance of ratings, with price targets adjusted accordingly. Nike's financial performance remains strong, with positive revenue growth, high net margin, and effective debt management, positioning it well in the athletic footwear and apparel industry.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 4:00 pm

JBL

Over the past 10 years, Jabil (NYSE:JBL) has produced an average annual return of 21.09%, outperforming the market by 10.6% annually. With a current market capitalization of $14.33 billion, a $1000 investment in JBL stock 10 years ago would be worth $6,761.24 today.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 4:00 pm